ES2174920T3 - Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. - Google Patents
Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno.Info
- Publication number
- ES2174920T3 ES2174920T3 ES95905102T ES95905102T ES2174920T3 ES 2174920 T3 ES2174920 T3 ES 2174920T3 ES 95905102 T ES95905102 T ES 95905102T ES 95905102 T ES95905102 T ES 95905102T ES 2174920 T3 ES2174920 T3 ES 2174920T3
- Authority
- ES
- Spain
- Prior art keywords
- combination product
- progesterone antagonist
- antagonist agents
- containing progesterone
- gestagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Abstract
LA PRESENTE INVENCION TRATA DE LA COMBINACION DE DOSIS INDIVIDUALES DE UN ANTAGONISTA COMPETITIVO DE LA PROGESTERONA Y, SECUENCIALMENTE, DOSIS INDIVIDUALES DE UN COMPUESTO CON EFECTO GESTAGENICO, ASI COMO SU UTILIZACION PARA HACER UN CONTRACEPTIVO BASADO EN IMPEDIR LA IMPLANTACION (INHIBICION DE LA RECEPTIVIDAD).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4344463A DE4344463A1 (de) | 1993-12-22 | 1993-12-22 | Kombinationsprodukt zur Kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2174920T3 true ES2174920T3 (es) | 2002-11-16 |
Family
ID=6506207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95905102T Expired - Lifetime ES2174920T3 (es) | 1993-12-22 | 1994-12-22 | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. |
Country Status (9)
Country | Link |
---|---|
US (1) | US6225297B1 (es) |
EP (1) | EP0735882B1 (es) |
JP (1) | JPH09510183A (es) |
AT (1) | ATE217192T1 (es) |
DE (2) | DE4344463A1 (es) |
DK (1) | DK0735882T3 (es) |
ES (1) | ES2174920T3 (es) |
PT (1) | PT735882E (es) |
WO (1) | WO1995017193A1 (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
DE19531936A1 (de) * | 1995-08-17 | 1997-02-20 | Schering Ag | Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend |
US6506390B2 (en) | 1996-06-25 | 2003-01-14 | Akzo Nobel | Progestogen-anti-progestogen regimens |
TR199802705T2 (xx) * | 1996-06-25 | 1999-03-22 | Akzo Nobel N.V. | Progestojen-anti-progestojen k�r� |
RU2215540C2 (ru) * | 1997-11-14 | 2003-11-10 | Акцо Нобель Н.В. | Схемы приема гестаген-антигестагена |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6380178B1 (en) * | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
SI1173210T1 (en) * | 1999-05-04 | 2005-02-28 | Wyeth | Contraceptive compositions containing antiprogestinic and progestinic |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6399593B1 (en) * | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
EP1173213A1 (en) * | 1999-05-04 | 2002-01-23 | American Home Products Corporation | Compositions containing benzimidazolones and progestogens |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
US20030219471A1 (en) * | 2002-03-11 | 2003-11-27 | Caubel Patrick Michel | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
BRPI0414945A (pt) * | 2003-10-01 | 2006-11-07 | Janssen Pharmaceutica Nv | regimes contraceptivos trifásicos estendidos |
WO2009082478A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
HUE055562T2 (hu) | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
EP3145489A1 (en) | 2014-05-22 | 2017-03-29 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
AU2015296609A1 (en) | 2014-07-29 | 2016-12-22 | Therapeuticsmd, Inc. | Transdermal cream |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3890356A (en) * | 1973-03-26 | 1975-06-17 | Richardson Merrell Inc | 7-Alkyl-{66 {hu 3,5{b -steroids |
US3928398A (en) * | 1973-11-01 | 1975-12-23 | Richardson Merrell Inc | Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol |
US4000273A (en) * | 1973-11-01 | 1976-12-28 | Richardson-Merrell Inc. | Method for the control of fertility |
US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
IL68222A (en) * | 1983-03-24 | 1987-02-27 | Yeda Res & Dev | Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity |
US5439913A (en) * | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5622943A (en) * | 1992-05-06 | 1997-04-22 | The Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
WO1993021926A1 (en) * | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
US5516769A (en) * | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
-
1993
- 1993-12-22 DE DE4344463A patent/DE4344463A1/de not_active Withdrawn
-
1994
- 1994-12-22 PT PT95905102T patent/PT735882E/pt unknown
- 1994-12-22 EP EP95905102A patent/EP0735882B1/de not_active Expired - Lifetime
- 1994-12-22 WO PCT/EP1994/004273 patent/WO1995017193A1/de active IP Right Grant
- 1994-12-22 DK DK95905102T patent/DK0735882T3/da active
- 1994-12-22 ES ES95905102T patent/ES2174920T3/es not_active Expired - Lifetime
- 1994-12-22 JP JP7517198A patent/JPH09510183A/ja active Pending
- 1994-12-22 DE DE59410116T patent/DE59410116D1/de not_active Expired - Lifetime
- 1994-12-22 US US08/666,592 patent/US6225297B1/en not_active Expired - Lifetime
- 1994-12-22 AT AT95905102T patent/ATE217192T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1995017193A1 (de) | 1995-06-29 |
DE4344463A1 (de) | 1995-06-29 |
JPH09510183A (ja) | 1997-10-14 |
EP0735882A1 (de) | 1996-10-09 |
ATE217192T1 (de) | 2002-05-15 |
EP0735882B1 (de) | 2002-05-08 |
DE59410116D1 (de) | 2002-06-13 |
DK0735882T3 (da) | 2002-07-29 |
PT735882E (pt) | 2002-10-31 |
US6225297B1 (en) | 2001-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2174920T3 (es) | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. | |
KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
BG101553A (en) | Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives | |
CA2195425A1 (en) | Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri | |
PT868188E (pt) | Kit para a contracepcao em mamiferos femininos consistindo numa combinacao de gestagenio e estrogenio | |
ES2114605T5 (es) | Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el. | |
PT835114E (pt) | Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal | |
RS50262B2 (sr) | Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva | |
TR199802705T2 (xx) | Progestojen-anti-progestojen k�r� | |
MX9702162A (es) | Procedimiento para hacer unidades de dosis mediante granulacion en humedo. | |
UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
PT100409A (pt) | Utilizacao de inibidores de aromatase, por exemplo derivados de imidazopiridina, para a anticoncepcao em primatas femeas sem afectar o ciclo menstrual | |
BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
WO1997006807A3 (de) | Kombinationspräparat zur kontrazeption, kits diese enthaltend und eine methode diese verwendend | |
BR9814136A (pt) | Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto. | |
BR9908605A (pt) | Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção | |
UA41351C2 (uk) | Спосіб контрацепції та набір таблеток | |
MX9707009A (es) | Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. | |
AR006437A1 (es) | Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 735882 Country of ref document: ES |